Take your assessment
Tell us about your health, weight history and goals.
Doctor-led weight loss for men, with monthly check-ins, dose reviews and ongoing support. Start an assessment to find out whether treatment is suitable for you.
Plans from £99 per 4-week cycle
On selected 12-month plans. Prices vary by treatment and dose.
Treatment options
Not sure which option suits you?
Your clinician will help you decide.
How Heracles compares
Personalised treatment, expert guidance and a plan to help you keep the weight off.
Results
Hunger and cravings
Reliance on willpower
Expert support
Nutrition course
Keeping weight off
20.9% average weight loss*
Help to reduce hunger
Healthy habits, with treatment to help
A plan to help keep it off
3.1% average weight loss*
Managed through food choices
Healthy habits on your own
Maintain your own routine
* SURMOUNT-1 trial averages at 72 weeks: tirzepatide 15 mg versus placebo, both with lifestyle support. Individual results vary. Full details below.
GETTING STARTED
Tell us about your health, weight history and goals.
Your clinical team reviews your assessment and considers the right plan for you.
If prescribed, your treatment arrives discreetly, with ongoing support.
Treatment is subject to clinical assessment.
Testimonials
Our clinical team
Eligibility depends on your BMI, health history and any weight-related conditions.
Treatment can reduce appetite and food noise, making it easier to eat less.
Monthly clinical check-ins review your progress and any side effects, so treatment can be adjusted or stopped when needed.
Your plan begins at the starting dose and moves to the next dose automatically every four weeks, unless your prescriber advises otherwise. Each dose has its own price, so your monthly cost increases as you move up. You’ll see the full dose and price schedule before you begin.
Your progress
Mounjaro, injectable Wegovy and oral Wegovy all start low and increase gradually. Your plan develops around your progress and how you’re feeling.
Start AssessmentYour first dose gives your body time to adjust. Some people begin to notice less hunger or fewer food thoughts.
As your dose increases, appetite control may become stronger—and better choices less of a battle.
Progress may begin to feel more visible. Clothes fit differently. The number starts moving in the right direction.
The changes add up. Less weight to carry, with routines that feel easier to keep.
Your treatment keeps working alongside you as you move towards a result you can feel as well as see.
Appetite and cravings
People describe less hunger, fewer cravings and fewer unwanted thoughts about food. Eating can feel easier to manage.
Experiences vary. Your clinician helps you find an approach that supports good nutrition as your appetite changes.
Weight-loss guides
What a clinical assessment covers and how care is monitored.
Read guide
What to expect as your treatment and habits develop.
Read guide
Practical guidance on nutrition, strength and protecting muscle.
Read guideExplore your energy, nutrition and hydration needs with our free calculators.
Heracles is designed for adult men. Prescription treatment is generally licensed for people with a BMI of 30 or above, or 27 or above with a weight-related health condition. Your assessment confirms whether treatment is suitable for you.See: Mounjaro prescribing information and Wegovy prescribing information.
No. You can complete the assessment directly. A Heracles specialist reviews your health and confirms whether treatment is appropriate.
Yes, and also the oral pills when clinically suitable. Complete the assessment to see the licensed prescription options available to you.
They act on signals involved in appetite and fullness. This can make smaller portions feel more satisfying and reduce the pull to keep eating.See: Mounjaro prescribing information, Wegovy prescribing information and Ard et al.
Food noise is the constant mental pull towards food: planning the next meal, thinking about snacks or struggling to feel satisfied. It is not a diagnosis, but it describes something many men recognise.Related evidence: GLP-1 appetite regulation and weight maintenance.
Tell us about your health, weight history and current medication. Choose your preferred treatment route, then a doctor checks that it is safe and clinically suitable.
Weight regain is common after treatment stops. In a major maintenance trial, people who stopped tirzepatide regained weight on average, while those who continued maintained and extended their weight loss. Your prescriber can help you plan for maintenance.Evidence: SURMOUNT-4 maintenance trial.
No. Treatment is only prescribed when a doctor decides it is appropriate for you. You will not be charged for medication unless it is prescribed.
You begin with the starting dose. Your dose is scheduled to increase every four weeks, giving your body time to adjust.See: Mounjaro dosing and Wegovy dosing.
Your dose moves to the next step automatically every four weeks, unless your prescriber advises otherwise. If you are experiencing side effects, contact the clinical team before your next increase. Licensed weekly treatments use gradual escalation to improve tolerability.See: NICE prescribing guidance, Mounjaro dosing and Wegovy dosing.
Yes. Each dose has its own price, so your monthly payment increases automatically as your dose rises. You will see the complete dose and price schedule before beginning treatment.
Your plan includes:
- Your prescribed medication
- Clinical review and prescribing
- Plain, unbranded delivery and dose reviews
- Access to the clinical team
- Access to the nutrition course
- Additional consultations and blood tests are available separately.
No. Blood testing is not included as standard. A clinician may recommend it when your history or symptoms suggest that a wider health check would be useful.
Results vary. The “up to 21%” figure shown on the page comes from a clinical trial over approximately 72 weeks; it is not a forecast or guarantee for every patient. Your progress depends on your treatment, dose, starting point and time on treatment.Evidence: SURMOUNT-1 tirzepatide trial.
Changes in appetite or food noise may be noticed before substantial changes on the scale. Meaningful weight loss develops over weeks and months, not overnight.
Plateaus happen. Your clinical team can review your dose, side effects, adherence and progress before deciding whether anything needs to change.
The most common effects involve digestion, including nausea, diarrhoea, constipation, vomiting and stomach discomfort. They are often more noticeable while the dose is increasing.See: Mounjaro patient leaflet and Wegovy patient leaflet.
Tell the clinical team rather than pushing through them. Your next increase may need to be delayed, or your dose may need to be reduced or stopped.See: NICE prescribing guidance and MHRA patient guidance.
Choose a rolling monthly plan that can be paused, or a 3-, 6- or 12-month contract. If you cancel a fixed-term contract early, the agreed term remains payable, subject to your statutory rights.
Seek urgent medical help for severe, persistent stomach pain—particularly if it travels to your back or comes with nausea and vomiting. This can be a sign of acute pancreatitis, a rare but serious complication.See: MHRA pancreatitis guidance, Mounjaro patient leaflet and Wegovy patient leaflet.
* In SURMOUNT-1, average weight loss at 72 weeks was 20.9% with tirzepatide 15 mg and 3.1% with placebo. Both groups received diet and physical activity support. The study involved adults with obesity, or overweight with a related health condition, without diabetes. Individual results vary; treatment is subject to clinical assessment. Other rows compare Heracles with self-directed diet and exercise. Weight can return after treatment stops.
Clinically reviewed by Peter Grice, Heracles Clinical Lead · September 2026
